Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.

Albers, G.; Bates, V.; Clark, W.; Bell, R.; Verro, P.; Hamilton, S.

doi:10.1001/JAMA.283.9.1145

Public

Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.

Shared by NobleBlocks on Mar 1, 2000 • 12:00 AM UTC

Authors:

Albers GW

Bates VE

Clark WM

Abstract

Context Tissue-type plasminogen activator (tPA) is the only therapy for acute ischemic stroke approved by the Food and Drug Administration.Objective To assess the safety profile and to document clinical outcomes and adverse events in patients treated with intravenous tPA for acute stroke in clinical...

Discussions